Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

BLPH Bellerophon Therapeutics

Watchlist
0.971
+0.045+4.86%
Close  12/09 16:00 ET
High
0.972
Open
0.930
Turnover
13.40K
Low
0.921
Pre Close
0.926
Volume
14.22K
Market Cap
9.27M
P/E(TTM)
Loss
52wk High
3.720
Shares
9.55M
P/E(Static)
Loss
52wk Low
0.670
Float Cap
6.79M
Bid/Ask %
-9.09%
Historical High
193.800
Shs Float
6.99M
Volume Ratio
2.27
Historical Low
0.670
Dividend TTM
--
Div Yield TTM
--
P/B
1.25
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.20%
Amplitude
5.52%
Avg Price
0.942
Lot Size
1
Float Cap
6.79M
Bid/Ask %
-9.09%
Historical High
193.800
Shs Float
6.99M
Volume Ratio
2.27
Historical Low
0.670
Dividend TTM
--
P/B
1.25
Dividend LFY
--
Turnover Ratio
0.20%
Amplitude
5.52%
Avg Price
0.942
Lot Size
1
Price Forecast

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
CEO: Mr. Peter Fernandes
Market: NASDAQ
Listing Date: 02/13/2015
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist